SCHEMBL20066552

SCHEMBL20066552

c1ccc(N(c2ccccc2)c2ccc3c(c2)C(c2ccccc2)(C2(c4ccccc4)c4ccccc4-c4ccc(N(c5ccccc5)c5ccccc5)cc42)c2ccccc2-3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ CRHBP P24387 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ CRHR2 Q13324 1/20 0.33
▸ TLR9 Q9NR96 1/20 0.33
▸ CFTR P13569 1/20 0.32
▸ GOPC Q9HD26 1/20 0.32
▸ THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20066890 0.95 ALDH1A1 (0.41) PDK2ALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL20066563 0.92 PDK2 (0.40) PDK2ALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL20066628 0.91 PDK2 (0.39) PDK2ALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL20066618 0.91 PDK2 (0.36) PDK2ALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL20066647 0.91 PDK2 (0.38) PDK2ALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL20066639 0.91 PDK2 (0.38) PDK2ALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL20066578 0.90 PDK2 (0.38) PDK2L3MBTL1TDP1MAPTMEN1
SCHEMBL20066620 0.88 PDK2 (0.34) PDK2ALDH1A1TDP1
SCHEMBL20066581 0.88 PDK2 (0.38) PDK2
SCHEMBL20066573 0.88 PDK2 (0.35) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10907093-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-02-02 — — US disclosed
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-19 — — US disclosed
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180105741-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME C1S, SCO2, CCND2 PDK2 1507/4885ALDH1A1 1274/4885L3MBTL1 1351/4885
US-10907093-B2 Condensed cyclic compound and organic light-emitting device including the same C1S, SCO2, CCND2 PDK2 1507/4885ALDH1A1 1274/4885L3MBTL1 1351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback